ASND Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ascendis Pharma A/S

Watchlist Manager

Watchlist

Price: 235.26 USD -1.83% Market Closed

Market Cap: $14.6B

	Ascendis Pharma A/S NASDAQ:ASND	DK
F	Fujitec Co Ltd TSE:6406	JP
	Wheaton Precious Metals Corp TSX:WPM	CA
	Naturgy Energy Group SA LSE:0NPV	ES
	DocuSign Inc BMV:DOCU	US
	Atlas Copco AB OTC:ATLCY	SE
	Wipro Ltd NSE:WIPRO	IN
G	GCP Applied Technologies Inc F:43G	US
	Dai Nippon Printing Co Ltd TSE:7912	JP
	MP Materials Corp NYSE:MP	US
	NWS Holdings Ltd HKEX:659	HK
	Swatch Group AG F:UHRN	CH
	FirstRand Ltd OTC:FANDF	ZA
T	Thaire Life Assurance PCL SET:THREL	TH

Profitability Summary

Ascendis Pharma A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

85%

Gross Margin is Increasing

84% > 89%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-133%

Operating Margin is Increasing

-741% > -1%

Exceptional Net Margin

57%

Negative 3Y Average Net Margin

-149%

Net Margin is Increasing

-730% > 57%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-126%

Free Cash Flow Margin is Increasing

-672% > 5%

Exceptional ROE

333%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-95%

ROIC is Increasing

-202% > 2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.